Issue 9/2009
Content (7 Articles)
Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension
David Montani, Marie-Camille Chaumais, Laurent Savale, Delphine Natali, Laura C. Price, Xavier Jaïs, Marc Humbert, Gérald Simonneau, Olivier Sitbon
Cost of atrial fibrillation in United States managed care organizations
Michael H. Kim, Jay Lin, Mohamed Hussein, Charles Kreilick, David Battleman
Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis
Joerg Gruenwald, Ellen Petzold, Regina Busch, Heinz-Peter Petzold, Hans-Joachim Graubaum
An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice
Lucas M. A. Goossens, Roland A. Riemersma, Dirkje S. Postma, Thys van der Molen, Maureen P. M. H. Rutten-van Mölken
Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer
Shilian Hu, Gan Shen, Shi Yin, Weiping Xu, Bing Hu